source
- Infant botulism cases linked to premium formulas raise safety concernsSeveral infants fell ill with botulism after consuming infant formula from the premium brand ByHeart, and a second brand, Nara Organics, has also been implicated. Health officials say the outbreak…
- cAMPfield Therapeutics raises $180 million to develop oral IBD drug prifemilastcAMPfield Therapeutics, a California biotech, announced a $180 million Series A financing to advance its oral anti‑inflammatory candidate for inflammatory bowel disease. The investigational drug,…